3-Methylglutaconic aciduria disorders: The clinical spectrum increases

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 2, 2006, Pages 62-63

  Arn, Pamela ^a   Funanage, Vicky L ^b  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUTACONIC ACID; 3 METHYLGLUTARIC ACID; 3 METHYLGLUTARYL COA HYDRATASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ACIDURIA; BARTH SYNDROME; COSTEFF OPTIC ATROPHY SYNDROME; DYSTONIA; ENZYME DEFICIENCY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERCHLOREMIC ACIDOSIS; METABOLIC ACIDOSIS; METABOLIC DISORDER; MYELODYSPLASTIC SYNDROME; NOTE; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; QUADRIPLEGIA;

CARDIOMYOPATHIES; CONSANGUINITY; GLUTARATES; HUMANS; HYDRO-LYASES; MALE; METABOLISM, INBORN ERRORS; MYELODYSPLASTIC SYNDROMES; PHENOTYPE; PROTEINS; TRANSCRIPTION FACTORS;

EID: 33644614705     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000199602.35010.89     Document Type: Note

References (11)

1. Gibson KM, Elpeleg ON, Jacobs C, et al. Multiple syndromes of 3-methylglutaconic aciduria. Pediatr Neurol. 1993;9:120-123.
2. Gibson KM, Sherwood WG, Hoffmann GF, et al. Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria. J Pediatr. 1991;118:885-890.
3. Gibson KM, Wappner RS, Jooste S, et al. Variable clinical presentation in three patients with 3-methylglutaconyl-coenzyme A hydratase deficiency. J. Inher. Metab. Dis. 1998;21:631-638.
4. Ijlst L, Loupatty FJ, Ruiter JPN, et al. 3-methylgutaconic aciduria type I is caused by mutations in AUH. Am J Hum Genet. 2002;71:1463-1466.
5. Ly TB, Peters V, Gibson KM, et al. Mutations in the AUH gene cause 3-methylglutaconic aciduria type I. Hum Mutat. 2003;2:401-407.
6. Bione S, D'Adamo P, Maestrini E, et al. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet. 1996;12:385-389.
7. Johnston J, Kelley RI, Feigenbaum A, et al. Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am J Hum Genet. 1997;61:1053-1058.
8. Barth PG, Valianpour F, Bowen VM, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A. 2004;126:349-354.
9. Anikster Y, Kleta K, Shaag A, et al. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001;69:1218-1224.
10. Gunay-Aygun M.3-methylglutaconic aciduria: a common biochemical marker in various syndromes with diverse clinical features. Mol Genet Metab. 2005;84:1-3.
11. Davey KM, Parboosingh JS, McLeod DR, et al. Mutation of DNAJC19, a human homolog of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J Med Genet. 2005 Aug 3; [E-pub ahead of print].